AU2001278849A1 - Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives - Google Patents

Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives

Info

Publication number
AU2001278849A1
AU2001278849A1 AU2001278849A AU7884901A AU2001278849A1 AU 2001278849 A1 AU2001278849 A1 AU 2001278849A1 AU 2001278849 A AU2001278849 A AU 2001278849A AU 7884901 A AU7884901 A AU 7884901A AU 2001278849 A1 AU2001278849 A1 AU 2001278849A1
Authority
AU
Australia
Prior art keywords
preparationswith
tetrahydropiperine
analogues
nutrients
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278849A
Other languages
English (en)
Inventor
Vladimir Badmaev
Kumar Rajinder Bammi
Muhammed Majeed
Sankaran Natarajan
Subbalakshmi Prakash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Original Assignee
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd, Sabinsa Corp filed Critical Sami Chemicals and Extracts Ltd
Publication of AU2001278849A1 publication Critical patent/AU2001278849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
AU2001278849A 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives Abandoned AU2001278849A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20524500P 2000-05-19 2000-05-19
US60205245 2000-05-19
US27797901P 2001-03-23 2001-03-23
US60277979 2001-03-23
PCT/US2001/016070 WO2001089571A2 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Publications (1)

Publication Number Publication Date
AU2001278849A1 true AU2001278849A1 (en) 2001-12-03

Family

ID=26900240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278849A Abandoned AU2001278849A1 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives

Country Status (6)

Country Link
US (1) US6849645B2 (https=)
JP (1) JP4098985B2 (https=)
AU (1) AU2001278849A1 (https=)
DE (2) DE10196213B4 (https=)
GB (1) GB2380675B (https=)
WO (1) WO2001089571A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105576B2 (en) * 2002-04-24 2006-09-12 Research Development Foundation Synergistic effects of nuclear transcription factor NF-κB inhibitors and anti-neoplastic agents
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2004067018A1 (en) * 2003-01-30 2004-08-12 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
AU2004320907A1 (en) 2003-08-26 2006-04-13 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
WO2006121421A2 (en) * 2004-01-14 2006-11-16 Robert Ritch Methods and formulations for treating glaucoma
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
US20080138417A1 (en) * 2006-11-22 2008-06-12 Charles Grigsby Topical Composition And Method Of Forming
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US10898537B2 (en) 2015-07-31 2021-01-26 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
KR102655937B1 (ko) * 2016-09-27 2024-04-11 (주)아모레퍼시픽 코스모페린을 포함하는 항스트레스 조성물
AU2017343886B2 (en) * 2016-10-14 2023-07-06 Cipla Limited Pharmaceutical compositions comprising rifaximin
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US20200268761A1 (en) * 2017-09-19 2020-08-27 Cipla Limited Compositions comprising ibrutinib and an alkaloid having enhanced bioavailability
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US20200179362A1 (en) * 2018-12-05 2020-06-11 James E. Beecham Dietary supplement comprising glucuronidation inhibition assist for healthful daily synergy of anti-inflammation, cellular anti-oxidant boost, cellular protein clean-up boost
JP7163261B2 (ja) * 2019-09-27 2022-10-31 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤
CN115670998A (zh) * 2022-11-18 2023-02-03 广州澳莱娜生物科技有限公司 一种祛痘控油亮肤组合物及其制备方法
CN115813822B (zh) * 2022-12-16 2024-06-25 厦门海尼新创生物科技有限公司 一种高效祛痘组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398259B (de) * 1982-09-30 1994-11-25 Dainippon Jochugiku Kk Thermischer räucherapparat für ein chemisches präparat
DE4392300T1 (de) * 1992-05-21 1995-12-07 Jeff J Staggs Therapeutische Gebräuche von beißenden Pflanzen und Ihre Verwandten Zusammensetzungen
CA2098889A1 (en) * 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
IN176897B (https=) * 1993-10-29 1996-09-28 Cadila Lab Ltd
US5439891A (en) * 1993-10-29 1995-08-08 Kapil; Randhir S. Process for preparation of pharmaceutical composition with enhanced activity for treatment of tuberculosis and leprosy
JP2946452B2 (ja) * 1994-11-04 1999-09-06 カディラ ラボラトリーズ リミテッド ピペリンを含む組成物
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
EP0935964A1 (en) * 1998-02-12 1999-08-18 Panacea Biotec Limited Pharmaceutical compositions containing NSAIDs and piperine
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders

Also Published As

Publication number Publication date
GB2380675A (en) 2003-04-16
WO2001089571A3 (en) 2002-03-07
DE10196213B4 (de) 2020-12-17
US20020058695A1 (en) 2002-05-16
JP4098985B2 (ja) 2008-06-11
GB0229561D0 (en) 2003-01-22
US6849645B2 (en) 2005-02-01
JP2003534295A (ja) 2003-11-18
GB2380675B (en) 2004-11-03
DE10196213T1 (de) 2003-04-30
WO2001089571A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001278849A1 (en) Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU772782C (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
AU2177001A (en) Use of indirubine derivatives for making medicines
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
PL352293A1 (en) Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU6359400A (en) Production of aliphatic fluorocarbons
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
AU2003294762A1 (en) Film-type preparations for transmucosal administration of nicotine and method for the production thereof
AU1036600A (en) Method for the production of quercetin and isoquercetin derivatives
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
AU2001252741A1 (en) Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof
MXPA03004938A (es) Procedimiento y derivados ester utiles para la preparacion de cefalosporinas.
AU3476300A (en) Improved mouse and method of using
SI1581258T1 (sl) Farmacevtska formulacija in postopek za njeno izdelavo
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU6046900A (en) Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom
AU2001269190A1 (en) Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
AU2001220267A1 (en) Novel 1beta-methylcarbapenem derivatives and process of preparation thereof
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition